EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lysophosphatidic acid mediates skeletal muscle fibrosis in denervation via activation of YAP/TAZ

Meilyn Cruz-Soca, Adriana Córdova-Casanova, Jennifer Faundez-Contreras, Nicolás W Martínez, Francesca Vaccaro-Rivera, Sebastián Bazaes-Astorga, Cristian Gutiérrez-Rojas, Felipe S Gallardo, Daniela L Rebolledo, Felipe A Court, Jerold Chun, Carlos P Vio und 3 weitere

JCI Insight · 2026

DOI: 10.1172/jci.insight.198388 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCI Insight, 2026. Verfasst von Meilyn Cruz-Soca und 14 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Medicina, Universidad San Sebastián, Providencia, Chile. Hauptthemen laut MEDLINE: Lysophospholipids, Muscle, Skeletal, Adaptor Proteins, Signal Transducing, Transcription Factors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Nacional de Investigación, Centro de Envejecimiento y Regeneración, Centro Científico y Tecnológico de Excelencia Ciencia & Vida.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lysophosphatidic acid (LPA) is a bioactive lipid that signals through G protein–coupled receptors (LPA 1–6 ) and regulates multiple cellular processes, including fibrosis. Although LPA signaling has been implicated in fibrotic diseases in several organs, its role in skeletal muscle remains unclear. Here, we show that LPA/LPA 1 signaling promotes fibrogenesis after sciatic nerve transection. Denervation induces differential expression of LPA signaling axis components and a transient early increase in intramuscular LPA levels. Pharmacological inhibition of LPA 1/3 with Ki16425, or genetic deletion of LPA 1 , reduces extracellular matrix accumulation and expansion of fibro/adipogenic progenitors (FAPs) in denervated muscle. Although LPA blockade suppresses atrophy-related gene expression, it does not fully preserve myofiber size. Mechanistically, denervation increases YAP/TAZ expression, nuclear localization in FAPs, and transcriptional activity, effects that are attenuated by LPA axis inhibition. Furthermore, pharmacological inhibition of YAP/TAZ with verteporfin reduces fibrosis after denervation, supporting their role as critical downstream mediators. Finally, transient denervation activates the LPA axis, promotes muscle fibrosis, reduces axonal density in the sciatic nerve, and increases neuromuscular junction instability, effects reversed by Ki16425. Together, these findings identify the LPA/LPA 1 /YAP/TAZ pathway as a key driver of denervation-induced muscle fibrosis and a potential therapeutic target in neuromuscular disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LysophospholipidsMuscle, SkeletalAdaptor Proteins, Signal TransducingTranscription FactorsAnimalsFibrosisYAP-Signaling ProteinsMiceSignal TransductionReceptors, Lysophosphatidic AcidMaleTrans-ActivatorsSciatic NerveIsoxazolesMuscle DenervationPropionatesCell Cycle ProteinsAcyltransferases

Stichwörter der Autor:innen

Cell biologyFibrosisMuscle biologySignal transductionSkeletal muscle

Substanzen

lysophosphatidic acidLysophospholipidsYAP-Signaling ProteinsYap1 protein, mouseReceptors, Lysophosphatidic AcidAdaptor Proteins, Signal TransducingTrans-ActivatorsTranscription FactorsIsoxazoles3-(4-(4-((1-(2-chlorophenyl)ethoxy)carbonyl amino)-3-methyl-5-isoxazolyl) benzylsulfanyl) propanoic acid

Autor:innen und Institutionen

  • Facultad de Medicina, Universidad San Sebastián, Providencia, Chile.
  • Centro Científico y Tecnológico de Excelencia Ciencia & Vida, Huechuraba, Chile.
  • Escuela de Kinesiología, Facultad de Ciencias, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile.
  • Buck Institute for Research on Aging, Novato, California, USA.
  • Center for Aging Research and Healthy Longevity, Faculty of Sciences, Universidad Mayor, Huechuraba, Chile.
  • Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA.

Förderung

  • Agencia Nacional de Investigación
  • Centro de Envejecimiento y Regeneración
  • Centro Científico y Tecnológico de Excelencia Ciencia & Vida

Zitieren

APA

Cruz-Soca, M., Córdova-Casanova, A., Faundez-Contreras, J., Martínez, N. W., Vaccaro-Rivera, F., Bazaes-Astorga, S., Gutiérrez-Rojas, C., Gallardo, F. S., Rebolledo, D. L., Court, F. A., Chun, J., Vio, C. P., Matus, S., Casar, J. C., & Brandan, E. (2026). Lysophosphatidic acid mediates skeletal muscle fibrosis in denervation via activation of YAP/TAZ. JCI Insight. https://doi.org/10.1172/jci.insight.198388

Vancouver

Cruz-Soca M, Córdova-Casanova A, Faundez-Contreras J, Martínez NW, Vaccaro-Rivera F, Bazaes-Astorga S, et al. Lysophosphatidic acid mediates skeletal muscle fibrosis in denervation via activation of YAP/TAZ. JCI Insight. 2026. doi:10.1172/jci.insight.198388

BibTeX
@article{CruzSoca2026,
  author = {Cruz-Soca, Meilyn and Córdova-Casanova, Adriana and Faundez-Contreras, Jennifer and Martínez, Nicolás W and Vaccaro-Rivera, Francesca and Bazaes-Astorga, Sebastián and Gutiérrez-Rojas, Cristian and Gallardo, Felipe S and Rebolledo, Daniela L and Court, Felipe A and Chun, Jerold and Vio, Carlos P and Matus, Soledad and Casar, Juan Carlos and Brandan, Enrique},
  title = {Lysophosphatidic acid mediates skeletal muscle fibrosis in denervation via activation of YAP/TAZ},
  journal = {JCI Insight},
  year = {2026},
  doi = {10.1172/jci.insight.198388}
}
Kostenlos starten →